A systematic review involving 228 patients with non‐alcoholic fatty liver disease (NAFLD) demonstrated that supplementation with curcumin or turmeric significantly reduced ALT and AST levels when administered at high doses exceeding 1000 mg/day over 8 weeks. Here, GPT is linked to metabolic dysfunction-associated steatotic liver disease.